To assess the risk factors for residual neuromuscular blockade following Rocuronium administration In children
Latest Information Update: 06 Dec 2021
At a glance
- Drugs Neostigmine (Primary) ; Rocuronium bromide (Primary) ; Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 06 Dec 2021 New trial record
- 12 Oct 2021 Results presented at the ANESTHESIOLOGY 2021 Annual Meeting of the American Society of Anesthesiologists